| 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) The … G Hindricks, T Potpara, N Dagres, E Arbelo, JJ Bax, ... European heart journal 42 (5), 373-498, 2021 | 6886 | 2021 |
| 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of … F Mach, C Baigent, AL Catapano, KC Koskinas, M Casula, L Badimon, ... European heart journal 41 (1), 111-188, 2020 | 6811 | 2020 |
| 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart … TA McDonagh, M Metra, M Adamo, RS Gardner, A Baumbach, M Böhm, ... European heart journal 42 (36), 3599-3726, 2021 | 6612 | 2021 |
| 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: the Task Force for the diagnosis and management of chronic coronary syndromes of the … J Knuuti, W Wijns, A Saraste, D Capodanno, E Barbato, ... European heart journal 41 (3), 407-477, 2020 | 5575 | 2020 |
| 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute … JP Collet, H Thiele, E Barbato, O Barthélémy, J Bauersachs, DL Bhatt, ... European heart journal 42 (14), 1289-1367, 2021 | 4203 | 2021 |
| 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and … F Cosentino, PJ Grant, V Aboyans, CJ Bailey, A Ceriello, V Delgado, ... European heart journal 41 (2), 255-323, 2020 | 3810 | 2020 |
| 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with … FLJ Visseren, F Mach, YM Smulders, D Carballo, KC Koskinas, M Bäck, ... European journal of preventive cardiology 29 (1), 5-115, 2022 | 2858 | 2022 |
| 2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of … A Vahanian, F Beyersdorf, F Praz, M Milojevic, S Baldus, J Bauersachs, ... European heart journal 43 (7), 561-632, 2022 | 2616 | 2022 |
| Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension MA Weber, EL Schiffrin, WB White, S Mann, LH Lindholm, JG Kenerson, ... The journal of clinical hypertension 16 (1), 14, 2014 | 2267 | 2014 |
| COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options TJ Guzik, SA Mohiddin, A Dimarco, V Patel, K Savvatis, FM Marelli-Berg, ... Cardiovascular research 116 (10), 1666-1687, 2020 | 1501 | 2020 |
| Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with … P Zhang, L Zhu, J Cai, F Lei, JJ Qin, J Xie, YM Liu, YC Zhao, X Huang, ... Circulation research 126 (12), 1671-1681, 2020 | 1245 | 2020 |
| Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms JR Petrie, TJ Guzik, RM Touyz Canadian Journal of Cardiology 34 (5), 575-584, 2018 | 1242 | 2018 |
| Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells RM Touyz, EL Schiffrin Pharmacological reviews 52 (4), 639-672, 2000 | 1210 | 2000 |
| 2020 ESC Guidelines for the management of adult congenital heart disease: the Task Force for the management of adult congenital heart disease of the European Society of … H Baumgartner, J De Backer, SV Babu-Narayan, W Budts, M Chessa, ... European heart journal 42 (6), 563-645, 2021 | 1145 | 2021 |
| 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European … M Glikson, JC Nielsen, MB Kronborg, Y Michowitz, A Auricchio, ... EP Europace 24 (1), 71-164, 2022 | 1139 | 2022 |
| Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? RM Touyz Hypertension 44 (3), 248-252, 2004 | 1136 | 2004 |
| 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease: The Task Force on sports cardiology and exercise in patients with cardiovascular … A Pelliccia, S Sharma, S Gati, M Bäck, M Börjesson, S Caselli, JP Collet, ... European heart journal 42 (1), 17-96, 2021 | 1097 | 2021 |
| 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the … M Humbert, G Kovacs, MM Hoeper, R Badagliacca, RMF Berger, M Brida, ... European heart journal 43 (38), 3618-3731, 2022 | 1026 | 2022 |
| NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities TM Paravicini, RM Touyz Diabetes care 31 (Supplement_2), S170-S180, 2008 | 979 | 2008 |
| Reactive oxygen species in vascular biology: implications in hypertension RM Touyz, EL Schiffrin Histochemistry and cell biology 122, 339-352, 2004 | 840 | 2004 |
Augusto MontezanoResearch Fellow, University of Glasgow在 glasgow.ac.uk 的电子邮件经过验证
